1050 related articles for article (PubMed ID: 28146296)
21. Effectiveness of Nasal Continuous Positive Airway Pressure vs Nasal Intermittent Positive Pressure Ventilation vs Noninvasive High-Frequency Oscillatory Ventilation as Support After Extubation of Neonates Born Extremely Preterm or With More Severe Respiratory Failure: A Secondary Analysis of a Randomized Clinical Trial.
Zhu X; Li F; Shi Y; Feng Z; De Luca D;
JAMA Netw Open; 2023 Jul; 6(7):e2321644. PubMed ID: 37399009
[TBL] [Abstract][Full Text] [Related]
22. Early erythropoiesis-stimulating agents in preterm or low birth weight infants.
Ohlsson A; Aher SM
Cochrane Database Syst Rev; 2017 Nov; 11(11):CD004863. PubMed ID: 29145693
[TBL] [Abstract][Full Text] [Related]
23. Continuous distending pressure for respiratory distress in preterm infants.
Ho JJ; Subramaniam P; Davis PG
Cochrane Database Syst Rev; 2015 Jul; 2015(7):CD002271. PubMed ID: 26141572
[TBL] [Abstract][Full Text] [Related]
24. Nasal continuous positive airways pressure immediately after extubation for preventing morbidity in preterm infants.
Davis PG; Henderson-Smart DJ
Cochrane Database Syst Rev; 2000; (3):CD000143. PubMed ID: 10908461
[TBL] [Abstract][Full Text] [Related]
25. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Shah SS
Cochrane Database Syst Rev; 2019 Jun; 6(6):CD004213. PubMed ID: 31222841
[TBL] [Abstract][Full Text] [Related]
26. Ibuprofen for the prevention of patent ductus arteriosus in preterm and/or low birth weight infants.
Ohlsson A; Shah SS
Cochrane Database Syst Rev; 2020 Jan; 1(1):CD004213. PubMed ID: 31985838
[TBL] [Abstract][Full Text] [Related]
27. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2018 Sep; 9(9):CD003481. PubMed ID: 30264852
[TBL] [Abstract][Full Text] [Related]
28. Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.
Crider K; Williams J; Qi YP; Gutman J; Yeung L; Mai C; Finkelstain J; Mehta S; Pons-Duran C; Menéndez C; Moraleda C; Rogers L; Daniels K; Green P
Cochrane Database Syst Rev; 2022 Feb; 2(2022):. PubMed ID: 36321557
[TBL] [Abstract][Full Text] [Related]
29. Inhaled versus systemic corticosteroids for preventing bronchopulmonary dysplasia in ventilated very low birth weight preterm neonates.
Shah SS; Ohlsson A; Halliday HL; Shah VS
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD002058. PubMed ID: 29041034
[TBL] [Abstract][Full Text] [Related]
30. Non-invasive ventilation for the management of acute hypercapnic respiratory failure due to exacerbation of chronic obstructive pulmonary disease.
Osadnik CR; Tee VS; Carson-Chahhoud KV; Picot J; Wedzicha JA; Smith BJ
Cochrane Database Syst Rev; 2017 Jul; 7(7):CD004104. PubMed ID: 28702957
[TBL] [Abstract][Full Text] [Related]
31. Nasal continuous positive airway pressure levels for the prevention of morbidity and mortality in preterm infants.
Bamat N; Fierro J; Mukerji A; Wright CJ; Millar D; Kirpalani H
Cochrane Database Syst Rev; 2021 Nov; 11(11):CD012778. PubMed ID: 34847243
[TBL] [Abstract][Full Text] [Related]
32. Laryngeal mask airway surfactant administration for prevention of morbidity and mortality in preterm infants with or at risk of respiratory distress syndrome.
Abdel-Latif ME; Walker E; Osborn DA
Cochrane Database Syst Rev; 2024 Jan; 1(1):CD008309. PubMed ID: 38270182
[TBL] [Abstract][Full Text] [Related]
33. Volume-targeted versus pressure-limited ventilation in neonates.
Klingenberg C; Wheeler KI; McCallion N; Morley CJ; Davis PG
Cochrane Database Syst Rev; 2017 Oct; 10(10):CD003666. PubMed ID: 29039883
[TBL] [Abstract][Full Text] [Related]
34. Inositol in preterm infants at risk for or having respiratory distress syndrome.
Howlett A; Ohlsson A; Plakkal N
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD000366. PubMed ID: 31283839
[TBL] [Abstract][Full Text] [Related]
35. Early surfactant administration with brief ventilation vs. selective surfactant and continued mechanical ventilation for preterm infants with or at risk for respiratory distress syndrome.
Stevens TP; Harrington EW; Blennow M; Soll RF
Cochrane Database Syst Rev; 2007 Oct; 2007(4):CD003063. PubMed ID: 17943779
[TBL] [Abstract][Full Text] [Related]
36. Ibuprofen for the treatment of patent ductus arteriosus in preterm or low birth weight (or both) infants.
Ohlsson A; Walia R; Shah SS
Cochrane Database Syst Rev; 2020 Feb; 2(2):CD003481. PubMed ID: 32045960
[TBL] [Abstract][Full Text] [Related]
37. Pharmacological interventions for prevention and treatment of upper gastrointestinal bleeding in newborn infants.
Green DS; Abdel-Latif ME; Jones LJ; Lui K; Osborn DA
Cochrane Database Syst Rev; 2019 Jul; 7(7):CD011785. PubMed ID: 31265739
[TBL] [Abstract][Full Text] [Related]
38. Laryngeal mask airway versus bag-mask ventilation or endotracheal intubation for neonatal resuscitation.
Qureshi MJ; Kumar M
Cochrane Database Syst Rev; 2018 Mar; 3(3):CD003314. PubMed ID: 29542112
[TBL] [Abstract][Full Text] [Related]
39. Prophylactic nasal continuous positive airway pressure for preventing morbidity and mortality in very preterm infants.
Subramaniam P; Ho JJ; Davis PG
Cochrane Database Syst Rev; 2016 Jun; (6):CD001243. PubMed ID: 27315509
[TBL] [Abstract][Full Text] [Related]
40. Interventions for the management of transient tachypnoea of the newborn - an overview of systematic reviews.
Bruschettini M; Hassan KO; Romantsik O; Banzi R; Calevo MG; Moresco L
Cochrane Database Syst Rev; 2022 Feb; 2(2):CD013563. PubMed ID: 35199848
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
